Stem cell therapy approved for clinical trials

Wednesday, December 08, 2010

A therapy developed by Palo Alto-based Stem Cells Inc. and researchers at U.C. Irvine has been approved for the world's first clinical trial using human neural stem cells to treat spinal cord injuries.

The treatment will target spinal injuries that are three to 12 months old.

Researchers will begin enrolling patients early next year.

(Copyright ©2014 KGO-TV. All Rights Reserved.)

Get more Health »

stem cell research, palo alto, health
blog comments powered by Disqus